Clinical Trial Update: Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on Botulinumtoxin A for Epidermolysis Bullosa Simplex and Pachyonychia Congenita; sponsor is Uppsala University and current phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epidermolysis Bullosa Simplex
• Pachyonychia Congenita

Drugs mentioned

• Botulinumtoxin A (botulinum toxin type A)

Snippet

Sponsor: Uppsala University | Conditions: Epidermolysis Bullosa Simplex | Phase 2 | Status: UNKNOWN